A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency

A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency

To identify novel host factors as putative targets to reverse HIV-1 latency, we performed an insertional mutagenesis genetic screen in a latent HIV-1 infected pseudohaploid KBM7 cell line (Hap-Lat). Following mutagenesis, insertions were mapped to the genome, and bioinformatic analysis resulted in t...

Full description

Saved in:
Bibliographic Details
Published in:mBio Vol. 12; no. 6; p. e0298021
Main Authors: Röling, Michael, Mollapour Sisakht, Mahsa, Ne, Enrico, Moulos, Panagiotis, Crespo, Raquel, Stoszko, Mateusz, De Crignis, Elisa, Bodmer, Helen, Kan, Tsung Wai, Akbarzadeh, Maryam, Harokopos, Vaggelis, Hatzis, Pantelis, Palstra, Robert-Jan, Mahmoudi, Tokameh
Format: Journal Article
Language:English
Published: United States American Society for Microbiology 21-12-2021
Subjects:
CD4-Positive T-Lymphocytes - metabolism
CD4-Positive T-Lymphocytes - virology
DNA Helicases - genetics
DNA Helicases - metabolism
DNA-Binding Proteins - genetics
DNA-Binding Proteins - metabolism
Gene Expression Regulation, Viral
Genetics and Molecular Biology
haploid forward genetic screen
Haploidy
HIV Infections - genetics
HIV Infections - metabolism
HIV Infections - virology
HIV-1 - genetics
HIV-1 - physiology
host factor
Host-Pathogen Interactions
human immunodeficiency virus
Humans
latency
Receptors, Kainic Acid - genetics
Receptors, Kainic Acid - metabolism
Research Article
Trans-Activators - genetics
Trans-Activators - metabolism
Transcription Factors - genetics
Transcription Factors - metabolism
Ubiquitin-Specific Proteases - genetics
Ubiquitin-Specific Proteases - metabolism
Virus Activation
Virus Latency
human immunodeficiency virus
haploid forward genetic screen
host factor
latency
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract To identify novel host factors as putative targets to reverse HIV-1 latency, we performed an insertional mutagenesis genetic screen in a latent HIV-1 infected pseudohaploid KBM7 cell line (Hap-Lat). Following mutagenesis, insertions were mapped to the genome, and bioinformatic analysis resulted in the identification of 69 candidate host genes involved in maintaining HIV-1 latency. A select set of candidate genes was functionally validated using short hairpin RNA (shRNA)-mediated depletion in latent HIV-1 infected J-Lat A2 and 11.1 T cell lines. We confirmed ADK, CHD9, CMSS1, EVI2B, EXOSC8, FAM19A, GRIK5, IRF2BP2, NF1, and USP15 as novel host factors involved in the maintenance of HIV-1 latency. Chromatin immunoprecipitation assays indicated that CHD9, a chromodomain helicase DNA-binding protein, maintains HIV-1 latency via direct association with the HIV-1 5' long terminal repeat (LTR), and its depletion results in increased histone acetylation at the HIV-1 promoter, concomitant with HIV-1 latency reversal. FDA-approved inhibitors 5-iodotubercidin, trametinib, and topiramate, targeting ADK, NF1, and GRIK5, respectively, were characterized for their latency reversal potential. While 5-iodotubercidin exhibited significant cytotoxicity in both J-Lat and primary CD4 T cells, trametinib reversed latency in J-Lat cells but not in latent HIV-1 infected primary CD4 T cells. Importantly, topiramate reversed latency in cell line models, in latently infected primary CD4 T cells, and crucially in CD4 T cells from three people living with HIV-1 (PLWH) under suppressive antiretroviral therapy, without inducing T cell activation or significant toxicity. Thus, using an adaptation of a haploid forward genetic screen, we identified novel and druggable host factors contributing to HIV-1 latency. A reservoir of latent HIV-1 infected cells persists in the presence of combination antiretroviral therapy (cART), representing a major obstacle for viral eradication. Reactivation of the latent HIV-1 provirus is part of curative strategies which aim to promote clearance of the infected cells. Using a two-color haploid screen, we identified 69 candidate genes as latency-maintaining host factors and functionally validated a subset of 10 of those in additional T-cell-based cell line models of HIV-1 latency. We further demonstrated that CHD9 is associated with HIV-1's promoter, the 5' LTR, while this association is lost upon reactivation. Additionally, we characterized the latency reversal potential of FDA compounds targeting ADK, NF1, and GRIK5 and identify the GRIK5 inhibitor topiramate as a viable latency reversal agent with clinical potential.
AbstractList A reservoir of latently HIV-1-infected cells persists in the presence of combination antiretroviral therapy (cART), representing a major obstacle for viral eradication. Reactivation of the latent HIV-1 provirus is part of curative strategies which aim to promote clearance of the infected cells. To identify novel host factors as putative targets to reverse HIV-1 latency, we performed an insertional mutagenesis genetic screen in a latent HIV-1 infected pseudohaploid KBM7 cell line (Hap-Lat). Following mutagenesis, insertions were mapped to the genome, and bioinformatic analysis resulted in the identification of 69 candidate host genes involved in maintaining HIV-1 latency. A select set of candidate genes was functionally validated using short hairpin RNA (shRNA)-mediated depletion in latent HIV-1 infected J-Lat A2 and 11.1 T cell lines. We confirmed ADK, CHD9, CMSS1, EVI2B, EXOSC8, FAM19A, GRIK5, IRF2BP2, NF1, and USP15 as novel host factors involved in the maintenance of HIV-1 latency. Chromatin immunoprecipitation assays indicated that CHD9, a chromodomain helicase DNA-binding protein, maintains HIV-1 latency via direct association with the HIV-1 5′ long terminal repeat (LTR), and its depletion results in increased histone acetylation at the HIV-1 promoter, concomitant with HIV-1 latency reversal. FDA-approved inhibitors 5-iodotubercidin, trametinib, and topiramate, targeting ADK, NF1, and GRIK5, respectively, were characterized for their latency reversal potential. While 5-iodotubercidin exhibited significant cytotoxicity in both J-Lat and primary CD4 + T cells, trametinib reversed latency in J-Lat cells but not in latent HIV-1 infected primary CD4 + T cells. Importantly, topiramate reversed latency in cell line models, in latently infected primary CD4 + T cells, and crucially in CD4 + T cells from three people living with HIV-1 (PLWH) under suppressive antiretroviral therapy, without inducing T cell activation or significant toxicity. Thus, using an adaptation of a haploid forward genetic screen, we identified novel and druggable host factors contributing to HIV-1 latency. IMPORTANCE A reservoir of latent HIV-1 infected cells persists in the presence of combination antiretroviral therapy (cART), representing a major obstacle for viral eradication. Reactivation of the latent HIV-1 provirus is part of curative strategies which aim to promote clearance of the infected cells. Using a two-color haploid screen, we identified 69 candidate genes as latency-maintaining host factors and functionally validated a subset of 10 of those in additional T-cell-based cell line models of HIV-1 latency. We further demonstrated that CHD9 is associated with HIV-1’s promoter, the 5′ LTR, while this association is lost upon reactivation. Additionally, we characterized the latency reversal potential of FDA compounds targeting ADK, NF1, and GRIK5 and identify the GRIK5 inhibitor topiramate as a viable latency reversal agent with clinical potential.
To identify novel host factors as putative targets to reverse HIV-1 latency, we performed an insertional mutagenesis genetic screen in a latent HIV-1 infected pseudohaploid KBM7 cell line (Hap-Lat). Following mutagenesis, insertions were mapped to the genome, and bioinformatic analysis resulted in the identification of 69 candidate host genes involved in maintaining HIV-1 latency. A select set of candidate genes was functionally validated using short hairpin RNA (shRNA)-mediated depletion in latent HIV-1 infected J-Lat A2 and 11.1 T cell lines. We confirmed ADK, CHD9, CMSS1, EVI2B, EXOSC8, FAM19A, GRIK5, IRF2BP2, NF1, and USP15 as novel host factors involved in the maintenance of HIV-1 latency. Chromatin immunoprecipitation assays indicated that CHD9, a chromodomain helicase DNA-binding protein, maintains HIV-1 latency via direct association with the HIV-1 5' long terminal repeat (LTR), and its depletion results in increased histone acetylation at the HIV-1 promoter, concomitant with HIV-1 latency reversal. FDA-approved inhibitors 5-iodotubercidin, trametinib, and topiramate, targeting ADK, NF1, and GRIK5, respectively, were characterized for their latency reversal potential. While 5-iodotubercidin exhibited significant cytotoxicity in both J-Lat and primary CD4 T cells, trametinib reversed latency in J-Lat cells but not in latent HIV-1 infected primary CD4 T cells. Importantly, topiramate reversed latency in cell line models, in latently infected primary CD4 T cells, and crucially in CD4 T cells from three people living with HIV-1 (PLWH) under suppressive antiretroviral therapy, without inducing T cell activation or significant toxicity. Thus, using an adaptation of a haploid forward genetic screen, we identified novel and druggable host factors contributing to HIV-1 latency. A reservoir of latent HIV-1 infected cells persists in the presence of combination antiretroviral therapy (cART), representing a major obstacle for viral eradication. Reactivation of the latent HIV-1 provirus is part of curative strategies which aim to promote clearance of the infected cells. Using a two-color haploid screen, we identified 69 candidate genes as latency-maintaining host factors and functionally validated a subset of 10 of those in additional T-cell-based cell line models of HIV-1 latency. We further demonstrated that CHD9 is associated with HIV-1's promoter, the 5' LTR, while this association is lost upon reactivation. Additionally, we characterized the latency reversal potential of FDA compounds targeting ADK, NF1, and GRIK5 and identify the GRIK5 inhibitor topiramate as a viable latency reversal agent with clinical potential.
ABSTRACT To identify novel host factors as putative targets to reverse HIV-1 latency, we performed an insertional mutagenesis genetic screen in a latent HIV-1 infected pseudohaploid KBM7 cell line (Hap-Lat). Following mutagenesis, insertions were mapped to the genome, and bioinformatic analysis resulted in the identification of 69 candidate host genes involved in maintaining HIV-1 latency. A select set of candidate genes was functionally validated using short hairpin RNA (shRNA)-mediated depletion in latent HIV-1 infected J-Lat A2 and 11.1 T cell lines. We confirmed ADK, CHD9, CMSS1, EVI2B, EXOSC8, FAM19A, GRIK5, IRF2BP2, NF1, and USP15 as novel host factors involved in the maintenance of HIV-1 latency. Chromatin immunoprecipitation assays indicated that CHD9, a chromodomain helicase DNA-binding protein, maintains HIV-1 latency via direct association with the HIV-1 5′ long terminal repeat (LTR), and its depletion results in increased histone acetylation at the HIV-1 promoter, concomitant with HIV-1 latency reversal. FDA-approved inhibitors 5-iodotubercidin, trametinib, and topiramate, targeting ADK, NF1, and GRIK5, respectively, were characterized for their latency reversal potential. While 5-iodotubercidin exhibited significant cytotoxicity in both J-Lat and primary CD4+ T cells, trametinib reversed latency in J-Lat cells but not in latent HIV-1 infected primary CD4+ T cells. Importantly, topiramate reversed latency in cell line models, in latently infected primary CD4+ T cells, and crucially in CD4+ T cells from three people living with HIV-1 (PLWH) under suppressive antiretroviral therapy, without inducing T cell activation or significant toxicity. Thus, using an adaptation of a haploid forward genetic screen, we identified novel and druggable host factors contributing to HIV-1 latency. IMPORTANCE A reservoir of latent HIV-1 infected cells persists in the presence of combination antiretroviral therapy (cART), representing a major obstacle for viral eradication. Reactivation of the latent HIV-1 provirus is part of curative strategies which aim to promote clearance of the infected cells. Using a two-color haploid screen, we identified 69 candidate genes as latency-maintaining host factors and functionally validated a subset of 10 of those in additional T-cell-based cell line models of HIV-1 latency. We further demonstrated that CHD9 is associated with HIV-1’s promoter, the 5′ LTR, while this association is lost upon reactivation. Additionally, we characterized the latency reversal potential of FDA compounds targeting ADK, NF1, and GRIK5 and identify the GRIK5 inhibitor topiramate as a viable latency reversal agent with clinical potential.
To identify novel host factors as putative targets to reverse HIV-1 latency, we performed an insertional mutagenesis genetic screen in a latent HIV-1 infected pseudohaploid KBM7 cell line (Hap-Lat). Following mutagenesis, insertions were mapped to the genome, and bioinformatic analysis resulted in the identification of 69 candidate host genes involved in maintaining HIV-1 latency. A select set of candidate genes was functionally validated using short hairpin RNA (shRNA)-mediated depletion in latent HIV-1 infected J-Lat A2 and 11.1 T cell lines. We confirmed ADK, CHD9, CMSS1, EVI2B, EXOSC8, FAM19A, GRIK5, IRF2BP2, NF1, and USP15 as novel host factors involved in the maintenance of HIV-1 latency. Chromatin immunoprecipitation assays indicated that CHD9, a chromodomain helicase DNA-binding protein, maintains HIV-1 latency via direct association with the HIV-1 5′ long terminal repeat (LTR), and its depletion results in increased histone acetylation at the HIV-1 promoter, concomitant with HIV-1 latency reversal. FDA-approved inhibitors 5-iodotubercidin, trametinib, and topiramate, targeting ADK, NF1, and GRIK5, respectively, were characterized for their latency reversal potential. While 5-iodotubercidin exhibited significant cytotoxicity in both J-Lat and primary CD4 + T cells, trametinib reversed latency in J-Lat cells but not in latent HIV-1 infected primary CD4 + T cells. Importantly, topiramate reversed latency in cell line models, in latently infected primary CD4 + T cells, and crucially in CD4 + T cells from three people living with HIV-1 (PLWH) under suppressive antiretroviral therapy, without inducing T cell activation or significant toxicity. Thus, using an adaptation of a haploid forward genetic screen, we identified novel and druggable host factors contributing to HIV-1 latency.
To identify novel host factors as putative targets to reverse HIV-1 latency, we performed an insertional mutagenesis genetic screen in a latent HIV-1 infected pseudohaploid KBM7 cell line (Hap-Lat). Following mutagenesis, insertions were mapped to the genome, and bioinformatic analysis resulted in the identification of 69 candidate host genes involved in maintaining HIV-1 latency. A select set of candidate genes was functionally validated using short hairpin RNA (shRNA)-mediated depletion in latent HIV-1 infected J-Lat A2 and 11.1 T cell lines. We confirmed ADK, CHD9, CMSS1, EVI2B, EXOSC8, FAM19A, GRIK5, IRF2BP2, NF1, and USP15 as novel host factors involved in the maintenance of HIV-1 latency. Chromatin immunoprecipitation assays indicated that CHD9, a chromodomain helicase DNA-binding protein, maintains HIV-1 latency via direct association with the HIV-1 5′ long terminal repeat (LTR), and its depletion results in increased histone acetylation at the HIV-1 promoter, concomitant with HIV-1 latency reversal. FDA-approved inhibitors 5-iodotubercidin, trametinib, and topiramate, targeting ADK, NF1, and GRIK5, respectively, were characterized for their latency reversal potential. While 5-iodotubercidin exhibited significant cytotoxicity in both J-Lat and primary CD4+ T cells, trametinib reversed latency in J-Lat cells but not in latent HIV-1 infected primary CD4+ T cells. Importantly, topiramate reversed latency in cell line models, in latently infected primary CD4+ T cells, and crucially in CD4+ T cells from three people living with HIV-1 (PLWH) under suppressive antiretroviral therapy, without inducing T cell activation or significant toxicity. Thus, using an adaptation of a haploid forward genetic screen, we identified novel and druggable host factors contributing to HIV-1 latency. IMPORTANCE A reservoir of latent HIV-1 infected cells persists in the presence of combination antiretroviral therapy (cART), representing a major obstacle for viral eradication. Reactivation of the latent HIV-1 provirus is part of curative strategies which aim to promote clearance of the infected cells. Using a two-color haploid screen, we identified 69 candidate genes as latency-maintaining host factors and functionally validated a subset of 10 of those in additional T-cell-based cell line models of HIV-1 latency. We further demonstrated that CHD9 is associated with HIV-1’s promoter, the 5′ LTR, while this association is lost upon reactivation. Additionally, we characterized the latency reversal potential of FDA compounds targeting ADK, NF1, and GRIK5 and identify the GRIK5 inhibitor topiramate as a viable latency reversal agent with clinical potential.
Author Moulos, Panagiotis
Akbarzadeh, Maryam
De Crignis, Elisa
Bodmer, Helen
Hatzis, Pantelis
Mollapour Sisakht, Mahsa
Ne, Enrico
Röling, Michael
Palstra, Robert-Jan
Harokopos, Vaggelis
Crespo, Raquel
Mahmoudi, Tokameh
Kan, Tsung Wai
Stoszko, Mateusz
Author_xml – sequence: 1
  givenname: Michael
  surname: Röling
  fullname: Röling, Michael
  organization: Department of Biochemistry, Erasmus University Medical Center, Rotterdam, the Netherlands
– sequence: 2
  givenname: Mahsa
  surname: Mollapour Sisakht
  fullname: Mollapour Sisakht, Mahsa
  organization: Stem Cell and Regenerative Medicine Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 3
  givenname: Enrico
  surname: Ne
  fullname: Ne, Enrico
  organization: Department of Biochemistry, Erasmus University Medical Center, Rotterdam, the Netherlands
– sequence: 4
  givenname: Panagiotis
  surname: Moulos
  fullname: Moulos, Panagiotis
  organization: Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
– sequence: 5
  givenname: Raquel
  surname: Crespo
  fullname: Crespo, Raquel
  organization: Department of Biochemistry, Erasmus University Medical Center, Rotterdam, the Netherlands
– sequence: 6
  givenname: Mateusz
  surname: Stoszko
  fullname: Stoszko, Mateusz
  organization: Department of Biochemistry, Erasmus University Medical Center, Rotterdam, the Netherlands
– sequence: 7
  givenname: Elisa
  surname: De Crignis
  fullname: De Crignis, Elisa
  organization: Department of Biochemistry, Erasmus University Medical Center, Rotterdam, the Netherlands
– sequence: 8
  givenname: Helen
  surname: Bodmer
  fullname: Bodmer, Helen
  organization: Department of Biochemistry, Erasmus University Medical Center, Rotterdam, the Netherlands
– sequence: 9
  givenname: Tsung Wai
  surname: Kan
  fullname: Kan, Tsung Wai
  organization: Department of Biochemistry, Erasmus University Medical Center, Rotterdam, the Netherlands
– sequence: 10
  givenname: Maryam
  surname: Akbarzadeh
  fullname: Akbarzadeh, Maryam
  organization: Stem Cell and Regenerative Medicine Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 11
  givenname: Vaggelis
  surname: Harokopos
  fullname: Harokopos, Vaggelis
  organization: Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
– sequence: 12
  givenname: Pantelis
  surname: Hatzis
  fullname: Hatzis, Pantelis
  organization: Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
– sequence: 13
  givenname: Robert-Jan
  surname: Palstra
  fullname: Palstra, Robert-Jan
  organization: Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands
– sequence: 14
  givenname: Tokameh
  orcidid: 0000-0002-2060-9353
  surname: Mahmoudi
  fullname: Mahmoudi, Tokameh
  organization: Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34872356$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1vEzEQxS1UREvpkSvyESFt8bfXF6Q2os1KERwoHLhYk91x2WhjB3sT1P-eTVOq9oAvY3mefjPP7zU5iikiIW85O-dc1B_Xl306Z8LVrBL8BTkRXLPKas6PntyPyVkpKzYdKXkt2StyLFVthdTmhPy8oDd_UjVLQ8p0Dpsh9R29xohj39JvbUaMtOkwjn3osdAvaYcDnacy0itox5QLbeIuDTvsaB_pvPlRcbqAEWN794a8DDAUPHuop-T71eeb2bxafL1uZheLCrQUY9UGY9Uy6MBYDRqsBa1ZALtsISydVrqzyojWBYXOaRBKW6O14a4DVMoJeUqaA7dLsPKb3K8h3_kEvb9_SPnWQ57sDOhFsMJ1NTOytkoL5xzIiaw5IkNwYWJ9OrA22-Uau3YynmF4Bn3eif0vf5t2vjbKWWsmwPsHQE6_t1hGv-5Li8MAEdO2eGGY1Y47s9-7OkjbnErJGB7HcOb38fp9vP4-Xi_4pP9w0ENZC79K2xynb_2v-N1TI4_of8nLv63krmc
CitedBy_id crossref_primary_10_3389_fcimb_2022_855092
crossref_primary_10_1093_nar_gkac407
crossref_primary_10_1097_COH_0000000000000808
crossref_primary_10_3389_fviro_2022_935933
crossref_primary_10_1016_j_isci_2024_109152
Cites_doi 10.1038/nature10348
10.1186/1742-4690-10-67
10.1371/journal.ppat.1009055
10.1371/journal.ppat.1004071
10.1371/journal.ppat.1008834
10.1016/j.celrep.2018.01.034
10.1371/journal.pcbi.1005950
10.1146/annurev.genom.8.080706.092424
10.1093/infdis/jiv219
10.1128/JVI.01181-08
10.1007/s00705-021-05021-1
10.1093/emboj/20.7.1726
10.1128/JCM.00055-08
10.15252/embr.201949305
10.1093/nar/28.3.663
10.1128/JVI.01208-07
10.1016/j.celrep.2014.09.031
10.1186/s12967-016-0853-5
10.1111/j.1528-1157.2000.tb02163.x
10.1006/excr.1999.4656
10.1093/database/bax028
10.1089/aid.2008.0191
10.1097/00002030-200405210-00003
10.1016/j.cell.2008.10.007
10.1093/bioinformatics/btp450
10.1038/s41467-018-07927-y
10.1038/nature23669
10.1016/j.chom.2009.05.022
10.1038/nature10117
10.1371/journal.pone.0070339
10.1038/ng.2471
10.1016/j.cub.2018.06.026
10.1242/jcs.238865
10.1073/pnas.1803468115
10.1007/s00018-019-03156-8
10.1016/j.chom.2017.09.002
10.1074/jbc.M114.589275
10.1038/nprot.2008.73
10.1038/s41586-018-0702-1
10.1074/jbc.M402124200
10.1080/14728222.2018.1465931
10.1083/jcb.201108103
10.1016/j.chom.2018.03.019
10.1126/sciadv.1701729
10.1126/science.1178955
10.1371/journal.ppat.1003997
10.1038/s41598-020-62375-3
10.1016/j.chom.2016.11.001
10.1124/mol.112.083352
10.1126/science.1233675
10.1038/487439a
10.1371/journal.pone.0048832
10.1128/jvi.74.15.6790-6799.2000
10.1016/bs.ircmb.2017.07.011
10.1038/sj.emboj.7600900
10.15252/msb.20145216
10.1038/s41564-020-0742-9
10.1371/journal.pone.0062527
10.1038/s41467-021-24462-5
10.1242/jcs.159103
10.1371/journal.ppat.1004473
10.1016/j.coviro.2019.06.001
10.1126/science.aac7557
10.1002/1521-4141(2002010)32:10<2783::AID-IMMU2783>3.0.CO;2-E
10.1073/pnas.1916290117
10.1371/journal.pbio.1001206
10.1038/s41591-019-0356-z
10.1124/pr.112.006361
10.1089/aid.1998.14.1315
10.1016/j.antiviral.2012.09.021
10.1038/nature21032
10.1016/j.chom.2019.11.010
10.1371/journal.pone.0212053
10.1101/cshperspect.a026450
10.1073/pnas.1018098108
10.1111/j.1528-1157.2000.tb02165.x
10.1002/j.1552-4604.1996.tb04754.x
10.1038/nature11286
10.1016/j.chom.2017.10.002
10.1016/j.cell.2015.02.009
10.1016/j.jneuroim.2010.11.014
10.1016/0009-2797(94)90028-0
10.1016/j.immuni.2018.04.030
10.1038/s41589-020-0594-x
10.1111/j.0013-9580.2003.06203.x
10.1093/nar/gkz493
10.2174/157016210793499312
10.1093/emboj/cdg188
10.1038/s41592-018-0107-y
10.1016/j.ymeth.2019.04.015
10.1126/sciadv.aba6617
10.1016/j.chom.2017.04.011
10.3390/v6041837
10.1371/journal.pone.0030176
10.3390/genes4040646
10.1016/j.bbrc.2017.11.177
10.1016/s0304-3940(97)00543-0
10.3389/fimmu.2019.01435
10.1073/pnas.1633296100
10.1007/s40265-013-0096-1
10.1128/MCB.00974-10
10.2139/ssrn.3553972
10.1007/978-1-4614-3903-5_2
10.1145/1645953.1646195
ContentType Journal Article
Copyright Copyright © 2021 Röling et al.
Copyright © 2021 Röling et al. 2021 Röling et al.
Copyright_xml – notice: Copyright © 2021 Röling et al.
– notice: Copyright © 2021 Röling et al. 2021 Röling et al.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1128/mBio.02980-21
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2150-7511
Editor Sluis-Cremer, Nicolas
Smithgall, Thomas E
Editor_xml – sequence: 1
  givenname: Nicolas
  surname: Sluis-Cremer
  fullname: Sluis-Cremer, Nicolas
– sequence: 2
  givenname: Thomas E
  surname: Smithgall
  fullname: Smithgall, Thomas E
– sequence: 2
  givenname: Thomas E.
  surname: Smithgall
  fullname: Smithgall, Thomas E.
EndPage e0298021
ExternalDocumentID oai_doaj_org_article_2f729d806387452999a3c9f51ee0ea9f
10_1128_mBio_02980_21
02980-21
34872356
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Dutch Aidsfonds
  grantid: 2016014
– fundername: ZonMW/Aidsfonds
  grantid: 446002508
– fundername: Dutch Aidsfonds
  grantid: 2014021
– fundername: Health Holland/Aidsfonds
  grantid: LSHM19100-SGF ICD-ICK4HIVCure
– fundername: ErasmusMC
  grantid: Mrace
– fundername: FP7 Ideas: European Research Council (IDEE-CER)
  grantid: FP/2007-2013 STG 337116 Trxn-PURGE
  funderid: https://doi.org/10.13039/100011199
– fundername: Dutch Aidsfonds
  grantid: small grant
– fundername: ;
  grantid: 2016014
– fundername: ;
  grantid: 446002508
– fundername: ;
  grantid: Mrace
– fundername: ;
  grantid: 2014021
– fundername: ;
  grantid: LSHM19100-SGF ICD-ICK4HIVCure
– fundername: ;
  grantid: FP/2007-2013 STG 337116 Trxn-PURGE
– fundername: ;
  grantid: small grant
GroupedDBID ---
0R~
53G
5VS
AAFWJ
AAUOK
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BTFSW
CGR
CUY
CVF
DIK
E3Z
EBS
ECM
EIF
FRP
GROUPED_DOAJ
GX1
H13
HYE
HZ~
KQ8
M48
M~E
NPM
O5R
O5S
O9-
OK1
P2P
PGMZT
RHF
RHI
RNS
RPM
RSF
-
0R
ADACO
BXI
HZ
AAYXX
CITATION
7X8
5PM
AFPKN
ID FETCH-LOGICAL-a532t-cf674bf5f008a5a77a550fa7bcafb9545d7462c9f4e995a2457655619dae44923
IEDL.DBID RPM
ISSN 2150-7511
IngestDate Tue Oct 22 15:10:34 EDT 2024
Tue Sep 17 21:04:04 EDT 2024
Fri Oct 25 00:10:43 EDT 2024
Thu Nov 21 21:36:13 EST 2024
Tue Feb 01 18:30:49 EST 2022
Wed Oct 16 00:41:41 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords human immunodeficiency virus
haploid forward genetic screen
host factor
latency
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a532t-cf674bf5f008a5a77a550fa7bcafb9545d7462c9f4e995a2457655619dae44923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Mahsa Mollapour Sisakht, Enrico Ne, Panagiotis Moulos, and Raquel Crespo contributed equally.
The authors declare no conflict of interest.
ORCID 0000-0002-2060-9353
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649776/
PMID 34872356
PQID 2607591962
PQPubID 23479
PageCount 23
ParticipantIDs doaj_primary_oai_doaj_org_article_2f729d806387452999a3c9f51ee0ea9f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8649776
proquest_miscellaneous_2607591962
crossref_primary_10_1128_mBio_02980_21
asm2_journals_10_1128_mBio_02980_21
pubmed_primary_34872356
PublicationCentury 2000
PublicationDate 2021-12-21
PublicationDateYYYYMMDD 2021-12-21
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-21
  day: 21
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle mBio
PublicationTitleAbbrev mBio
PublicationTitleAlternate mBio
PublicationYear 2021
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References Sadowski, I, Hashemi, FB (B18) 2019; 76
Reiling, JH, Clish, CB, Carette, JE, Varadarajan, M, Brummelkamp, TR, Sabatini, DM (B36) 2011; 108
Goff, SP (B25) 2008; 135
Staring, J, Von Castelmur, E, Blomen, VA, Van Den Hengel, LG, Brockmann, M, Baggen, J, Thibaut, HJ, Nieuwenhuis, J, Janssen, H, Van Kuppeveld, FJM, Perrakis, A, Carette, JE, Brummelkamp, TR (B48) 2017; 541
Razooky, BS, Pai, A, Aull, K, Rouzine, IM, Weinberger, LS (B84) 2015; 160
White, HS, Brown, SD, Woodhead, JH, Skeen, GA, Wolf, HH (B100) 2000; 41
Heijink, AM, Talens, F, Jae, LT, van Gijn, SE, Fehrmann, RSN, Brummelkamp, TR, van Vugt, MATM (B40) 2019; 10
Besnard, E, Hakre, S, Kampmann, M, Lim, HW, Hosmane, NN, Martin, A, Bassik, MC, Verschueren, E, Battivelli, E, Chan, J, Svensson, JP, Gramatica, A, Conrad, RJ, Ott, M, Greene, WC, Krogan, NJ, Siliciano, RF, Weissman, JS, Verdin, E (B21) 2016; 20
Stoszko, M, Al-Hatmi, AMS, Skriba, A, Roling, M, Ne, E, Crespo, R, Mueller, YM, Najafzadeh, MJ, Kang, J, Ptackova, R, LeMasters, E, Biswas, P, Bertoldi, A, Kan, TW, de Crignis, E, Sulc, M, Lebbink, JHG, Rokx, C, Verbon, A, van Ijcken, W, Katsikis, PD, Palstra, R-J, Havlicek, V, de Hoog, S, Mahmoudi, T (B78) 2020; 6
Ptak, RG, Borysko, KZ, Porcari, AR, Buthod, JL, Holland, LE, Shipman, C, Townsend, LB, Drach, JC (B94) 1998; 14
Mezzadra, R, Sun, C, Jae, LT, Gomez-Eerland, R, De Vries, E, Wu, W, Logtenberg, MEW, Slagter, M, Rozeman, EA, Hofland, I, Broeks, A, Horlings, HM, Wessels, LFA, Blank, CU, Xiao, Y, Heck, AJR, Borst, J, Brummelkamp, TR, Schumacher, TNM (B41) 2017; 549
Hansen, MMK, Martin, B, Weinberger, LS (B85) 2019; 26
Boehm, D, Jeng, M, Camus, G, Gramatica, A, Schwarzer, R, Johnson, JR, Hull, PA, Montano, M, Sakane, N, Pagans, S, Godin, R, Deeks, SG, Krogan, NJ, Greene, WC, Ott, M (B32) 2017; 21
Logtenberg, MEW, Jansen, JHM, Raaben, M, Toebes, M, Franke, K, Brandsma, AM, Matlung, HL, Fauster, A, Gomez-Eerland, R, Bakker, NAM, van der Schot, S, Marijt, KA, Verdoes, M, Haanen, JBAG, van den Berg, JH, Neefjes, J, van den Berg, TK, Brummelkamp, TR, Leusen, JHW, Scheeren, FA, Schumacher, TN (B38) 2019; 25
Schmittgen, TD, Livak, KJ (B103) 2008; 3
Rathore, A, Iketani, S, Wang, P, Jia, M, Sahi, V, Ho, DD (B26) 2020; 10
Janssen, LME, Averink, TV, Blomen, VA, Brummelkamp, TR, Medema, RH, Raaijmakers, JA (B42) 2018; 28
Coull, JJ, Romerio, F, Sun, JM, Volker, JL, Galvin, KM, Davie, JR, Shi, Y, Hansen, U, Margolis, DM (B12) 2000; 74
Jordan, A, Defechereux, P, Verdin, E (B65) 2001; 20
Laguette, N, Sobhian, B, Casartelli, N, Ringeard, M, Chable-Bessia, C, Ségéral, E, Yatim, A, Emiliani, S, Schwartz, O, Benkirane, M (B60) 2011; 474
Jiang, W-M, Zhang, X-Y, Zhang, Y-Z, Liu, L, Lu, H-Z (B20) 2014; 7
Wei, DG, Chiang, V, Fyne, E, Balakrishnan, M, Barnes, T, Graupe, M, Hesselgesser, J, Irrinki, A, Murry, JP, Stepan, G, Stray, KM, Tsai, A, Yu, H, Spindler, J, Kearney, M, Spina, CA, McMahon, D, Lalezari, J, Sloan, D, Mellors, J, Geleziunas, R, Cihlar, T (B9) 2014; 10
Wong, ME, Jaworowski, A, Hearps, AC (B80) 2019; 10
Rafati, H, Parra, M, Hakre, S, Moshkin, Y, Verdin, E, Mahmoudi, T (B57) 2011; 9
Goswami, R, Gershburg, S, Satorius, A, Gershburg, E (B93) 2012; 96
Sturgill, JL, Mathews, J, Scherle, P, Conrad, DH (B98) 2011; 233
Li, Z, Hajian, C, Greene, WC (B23) 2020; 16
Tantale, K, Garcia-Oliver, E, Robert, M-C, L’Hostis, A, Yang, Y, Tsanov, N, Topno, R, Gostan, T, Kozulic-Pirher, A, Basu-Shrivastava, M, Mukherjee, K, Slaninova, V, Andrau, J-C, Mueller, F, Basyuk, E, Radulescu, O, Bertrand, E (B86) 2021; 12
Lee, CC, Carette, JE, Brummelkamp, TR, Ploegh, HL (B45) 2013; 8
Carette, JE, Guimaraes, CP, Varadarajan, M, Park, AS, Wuethrich, I, Godarova, A, Kotecki, M, Cochran, BH, Spooner, E, Ploegh, HL, Brummelkamp, TR (B35) 2009; 326
Blomen, VA, Májek, P, Jae, LT, Bigenzahn, JW, Nieuwenhuis, J, Staring, J, Sacco, R, Van Diemen, FR, Olk, N, Stukalov, A, Marceau, C, Janssen, H, Carette, JE, Bennett, KL, Colinge, J, Superti-Furga, G, Brummelkamp, TR (B44) 2015; 350
Mayor-Ruiz, C, Bauer, S, Brand, M, Kozicka, Z, Siklos, M, Imrichova, H, Kaltheuner, IH, Hahn, E, Seiler, K, Koren, A, Petzold, G, Fellner, M, Bock, C, Müller, AC, Zuber, J, Geyer, M, Thomä, NH, Kubicek, S, Winter, GE (B63) 2020; 16
Elliott, JH, Wightman, F, Solomon, A, Ghneim, K, Ahlers, J, Cameron, MJ, Smith, MZ, Spelman, T, McMahon, J, Velayudham, P, Brown, G, Roney, J, Watson, J, Prince, MH, Hoy, JF, Chomont, N, Fromentin, R, Procopio, FA, Zeidan, J, Palmer, S, Odevall, L, Johnstone, RW, Martin, BP, Sinclair, E, Deeks, SG, Hazuda, DJ, Cameron, PU, Sékaly, R-P, Lewin, SR (B17) 2014; 10
Krasnopolsky, S, Kuzmina, A, Taube, R (B27) 2020; 16
Birsoy, K, Wang, T, Possemato, R, Yilmaz, OH, Koch, CE, Chen, WW, Hutchins, AW, Gultekin, Y, Peterson, TR, Carette, JE, Brummelkamp, TR, Clish, CB, Sabatini, DM (B37) 2013; 45
Timmons, A, Fray, E, Kumar, M, Wu, F, Dai, W, Bullen, CK, Kim, P, Hetzel, C, Yang, C, Beg, S, Lai, J, Pomerantz, JL, Yukl, SA, Siliciano, JD, Siliciano, RF (B89) 2020; 117
Kotecki, M, Reddy, PS, Cochran, BH (B34) 1999; 252
Shank, RP, Gardocki, JF, Streeter, AJ, Maryanoff, BE (B73) 2000; 41
Ying, H, Zhang, Y, Zhou, X, Qu, X, Wang, P, Liu, S, Lu, D, Zhu, H (B10) 2012; 7
Jordan, A, Bisgrove, D, Verdin, E (B56) 2003; 22
Hoffmann, HH, Schneider, WM, Blomen, VA, Scull, MA, Hovnanian, A, Brummelkamp, TR, Rice, CM (B49) 2017; 22
Mezzadra, R, De Bruijn, M, Jae, LT, Gomez-Eerland, R, Duursma, A, Scheeren, FA, Brummelkamp, TR, Schumacher, TN (B39) 2019; 14
Williams, SA, Chen, L-F, Kwon, H, Ruiz-Jarabo, CM, Verdin, E, Greene, WC (B11) 2006; 25
Accolla, RS, Mazza, S, De Lerma Barbaro, A, De Maria, A, Tosi, G (B67) 2002; 32
Staring, J, van den Hengel, LG, Raaben, M, Blomen, VA, Carette, JE, Brummelkamp, TR (B51) 2018; 23
Das, B, Dobrowolski, C, Luttge, B, Valadkhan, S, Chomont, N, Johnston, R, Bacchetti, P, Hoh, R, Gandhi, M, Deeks, SG, Scully, E, Karn, J (B19) 2018; 115
Klase, Z, Yedavalli, VSRK, Houzet, L, Perkins, M, Maldarelli, F, Brenchley, J, Strebel, K, Liu, P, Jeang, K-T (B91) 2014; 10
B104
Deeks, SG (B3) 2012; 487
Stewart, DRH, Clark, GJ (B75) 2020; 133
Zhu, J, Davoli, T, Perriera, JM, Chin, CR, Gaiha, GD, John, SP, Sigiollot, FD, Gao, G, Xu, Q, Qu, H, Pertel, T, Sims, JS, Smith, JA, Baker, RE, Maranda, L, Ng, A, Elledge, SJ, Brass, AL (B22) 2014; 9
Goujon, C, Arfi, V, Pertel, T, Luban, J, Lienard, J, Rigal, D, Darlix, J-L, Cimarelli, A (B58) 2008; 82
Piette, J, Legrand-Poels, S (B87) 1994; 91
Minin, GD, Postlmayr, A, Wutz, A (B62) 2018; 14
Lassen, KG, Hebbeler, AM, Bhattacharyya, D, Lobritz, MA, Greene, WC (B77) 2012; 7
Van Lint, C, Bouchat, S, Marcello, A (B5) 2013; 10
Kriegel, H-P, Kröger, P, Schubert, E, Zimek, A (B90) 2009
Huang, H, Kong, W, Jean, M, Fiches, G, Zhou, D, Hayashi, T, Que, J, Santoso, N, Zhu, J (B28) 2019; 47
Raaben, M, Jae, LT, Herbert, AS, Kuehne, AI, Stubbs, SH, Chou, Y, Blomen, VA, Kirchhausen, T, Dye, JM, Brummelkamp, TR, Whelan, SP (B50) 2017; 22
Archin, NM, Espeseth, A, Parker, D, Cheema, M, Hazuda, D, Margolis, DM (B7) 2009; 25
Yang, X, Wang, Y, Lu, P, Shen, Y, Zhao, X, Zhu, Y, Jiang, Z, Yang, H, Pan, H, Zhao, L, Zhong, Y, Wang, J, Liang, Z, Shen, X, Lu, D, Jiang, S, Xu, J, Wu, H, Lu, H, Jiang, G, Zhu, H (B24) 2020; 21
Jae, LT, Raaben, M, Riemersma, M, Van Beusekom, E, Blomen, VA, Velds, A, Kerkhoven, RM, Carette, JE, Topaloglu, H, Meinecke, P, Wessels, MW, Lefeber, DJ, Whelan, SP, Van Bokhoven, H, Brummelkamp, TR (B47) 2013; 340
Vallejo-Gracia, A, Chen, IP, Perrone, R, Besnard, E, Boehm, D, Battivelli, E, Tezil, T, Krey, K, Raymond, KA, Hull, PA, Walter, M, Habrylo, I, Cruz, A, Deeks, S, Pillai, S, Verdin, E, Ott, M (B88) 2020; 5
Pérez, M, de Vinuesa, AG, Sanchez-Duffhues, G, Marquez, N, Bellido, ML, Muñoz-Fernandez, MA, Moreno, S, Castor, TP, Calzado, MA, Muñoz, E (B15) 2010; 8
Palstra, R-J, Crignis, E, Röling, MD, Staveren, T, van Kan, TW, Ijcken, W, van Mueller, YM, Katsikis, PD, Mahmoudi, T (B64) 2018; 4
Valencia, HJ, de Aguiar, MCAM, Costa, MA, Mendonça, DC, Reis, EV, Arias, NEC, Drumond, BP, Bonjardim, CA (B95) 2021; 166
Kumar, A, Abbas, W, Herbein, G (B79) 2014; 6
Jangra, RK, Herbert, AS, Li, R, Jae, LT, Kleinfelter, LM, Slough, MM, Barker, SL, Guardado-Calvo, P, Román-Sosa, G, Dieterle, ME, Kuehne, AI, Muena, NA, Wirchnianski, AS, Nyakatura, EK, Fels, JM, Ng, M, Mittler, E, Pan, J, Bharrhan, S, Wec, AZ, Lai, JR, Sidhu, SS, Tischler, ND, Rey, FA, Moffat, J, Brummelkamp, TR, Wang, Z, Dye, JM, Chandran, K (B52) 2018; 563
Ne, E, Palstra, R-J, Mahmoudi, T (B4) 2018; 335
Carette, JE, Raaben, M, Wong, AC, Herbert, AS, Obernosterer, G, Mulherkar, N, Kuehne, AI, Kranzusch, PJ, Griffin, AM, Ruthel, G, Cin, PD, Dye, JM, Whelan, SP, Chandran, K, Brummelkamp, TR (B46) 2011; 477
Archin, NM, Liberty, AL, Kashuba, AD, Choudhary, SK, Kuruc, JD, Crooks, AM, Parker, DC, Anderson, EM, Kearney, MF, Strain, MC, Richman, DD, Hudgens, MG, Bosch, RJ, Coffin, JM, Eron, JJ, Hazuda, DJ, Margolis, DM (B16) 2012; 487
Morgan, M, Anders, S, Lawrence, M, Aboyoun, P, Pagès, H, Gentleman, R (B102) 2009; 25
Jiang, G, Espeseth, A, Hazuda, DJ, Margolis, DM (B13) 2007; 81
Stoszko, M, Ne, E, Abner, E, Mahmoudi, T (B92) 2019; 38
Fishilevich, S, Nudel, R, Rappaport, N, Hadar, R, Plaschkes, I, Iny Stein, T, Rosen, N, Kohn, A, Twik, M, Safran, M, Lancet, D, Cohen, D (B81) 2017; 2017
Rojas, A, Dingledine, R (B72) 2013; 83
Sengupta, S, Siliciano, RF (B2) 2018; 48
Walker, JA, Upadhyaya, M (B74) 2018; 22
Ylisastigui, L, Archin, NM, Lehrman, G, Bosch, RJ, Margolis, DM (B8) 2004; 18
Martin, SE, Caplen, NJ (B29) 2007; 8
Raaijmakers, JA, van Heesbeen, RGHP, Blomen, VA, Janssen, LME, van Diemen, F, Brummelkamp, TR, Medema, RH (B43) 2018; 22
Nallani, SC, Glauser, TA, Hariparsad, N, Setchell, K, Buckley, DJ, Buckley, AR, Desai, PB (B101) 2003; 44
Lai, B, Tang, Q, Jin, W, Hu, G, Wangsa, D, Cui, K, Stanton, BZ, Ren, G, Ding, Y, Zhao, M, Liu, S, Song, J, Ried, T, Zhao, K (B82) 2018; 15
Hart, T, Brown, KR, Sircoulomb, F, Rottapel, R, Moffat, J (B31) 2014; 10
Tafesse, FG, Guimaraes, CP, Maruyama, T, Carette, JE, Lory, S, Brummelkamp, TR, Ploegh, HL (B55) 2014; 289
Yu, JSL, Yusa, K (B33) 2019; 164-165
Pasternak, AO, Adema, KW,
e_1_3_2_28_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_62_2
e_1_3_2_85_2
e_1_3_2_24_2
e_1_3_2_47_2
e_1_3_2_66_2
e_1_3_2_89_2
e_1_3_2_100_2
e_1_3_2_104_2
e_1_3_2_81_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_39_2
e_1_3_2_54_2
e_1_3_2_31_2
e_1_3_2_73_2
e_1_3_2_12_2
e_1_3_2_58_2
e_1_3_2_96_2
e_1_3_2_3_2
e_1_3_2_35_2
e_1_3_2_77_2
e_1_3_2_92_2
e_1_3_2_50_2
e_1_3_2_48_2
e_1_3_2_29_2
e_1_3_2_40_2
e_1_3_2_86_2
e_1_3_2_63_2
e_1_3_2_44_2
e_1_3_2_25_2
e_1_3_2_67_2
e_1_3_2_82_2
e_1_3_2_103_2
e_1_3_2_17_2
e_1_3_2_59_2
e_1_3_2_6_2
e_1_3_2_32_2
e_1_3_2_51_2
e_1_3_2_74_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_55_2
e_1_3_2_78_2
e_1_3_2_97_2
e_1_3_2_2_2
e_1_3_2_93_2
e_1_3_2_70_2
Jiang W-M (e_1_3_2_21_2) 2014; 7
e_1_3_2_26_2
e_1_3_2_49_2
e_1_3_2_41_2
e_1_3_2_64_2
e_1_3_2_87_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_68_2
e_1_3_2_60_2
e_1_3_2_83_2
e_1_3_2_102_2
e_1_3_2_106_2
e_1_3_2_9_2
e_1_3_2_37_2
e_1_3_2_18_2
e_1_3_2_75_2
e_1_3_2_10_2
e_1_3_2_52_2
e_1_3_2_5_2
e_1_3_2_33_2
e_1_3_2_79_2
e_1_3_2_14_2
e_1_3_2_56_2
e_1_3_2_98_2
e_1_3_2_94_2
e_1_3_2_71_2
e_1_3_2_90_2
e_1_3_2_27_2
e_1_3_2_65_2
e_1_3_2_42_2
e_1_3_2_84_2
e_1_3_2_23_2
e_1_3_2_69_2
e_1_3_2_46_2
e_1_3_2_88_2
e_1_3_2_61_2
e_1_3_2_80_2
e_1_3_2_101_2
e_1_3_2_105_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_53_2
e_1_3_2_76_2
e_1_3_2_99_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_57_2
e_1_3_2_95_2
e_1_3_2_4_2
e_1_3_2_91_2
e_1_3_2_72_2
References_xml – volume: 477
  start-page: 340
  year: 2011
  end-page: 343
  ident: B46
  article-title: Ebola virus entry requires the cholesterol transporter Niemann-Pick C1
  publication-title: Nature
  doi: 10.1038/nature10348
  contributor:
    fullname: Brummelkamp, TR
– start-page: 1649
  year: 2009
  end-page: 1652
  ident: B90
  article-title: LoOP: local outlier probabilities
  publication-title: Proceedings of the 18th ACM Conference on Information and Knowledge Management (CIKM ‘09) ;Association for Computing Machinery ;New York, NY
  contributor:
    fullname: Zimek, A
– volume: 10
  start-page: 67
  year: 2013
  ident: B5
  article-title: HIV-1 transcription and latency: an update
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-10-67
  contributor:
    fullname: Marcello, A
– volume: 16
  year: 2020
  ident: B23
  article-title: Identification of unrecognized host factors promoting HIV-1 latency
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1009055
  contributor:
    fullname: Greene, WC
– volume: 10
  year: 2014
  ident: B9
  article-title: Histone deacetylase inhibitor romidepsin induces HIV-1 expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1004071
  contributor:
    fullname: Cihlar, T
– volume: 16
  year: 2020
  ident: B27
  article-title: Genome-wide CRISPR knockout screen identifies ZNF304 as a silencer of HIV-1 transcription that promotes viral latency
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1008834
  contributor:
    fullname: Taube, R
– volume: 22
  start-page: 1424
  year: 2018
  end-page: 1438
  ident: B43
  article-title: BUB1 is essential for the viability of human cells in which the spindle assembly checkpoint is compromised
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2018.01.034
  contributor:
    fullname: Medema, RH
– volume: 14
  year: 2018
  ident: B62
  article-title: HaSAPPy: a tool for candidate identification in pooled forward genetic screens of haploid mammalian cells
  publication-title: PLoS Comput Biol
  doi: 10.1371/journal.pcbi.1005950
  contributor:
    fullname: Wutz, A
– volume: 8
  start-page: 81
  year: 2007
  end-page: 108
  ident: B29
  article-title: Applications of RNA interference in mammalian systems
  publication-title: Annu Rev Genomics Hum Genet
  doi: 10.1146/annurev.genom.8.080706.092424
  contributor:
    fullname: Caplen, NJ
– volume: 212
  start-page: 1345
  year: 2015
  end-page: 1347
  ident: B1
  article-title: The remarkable stability of the latent reservoir for HIV-1 in resting memory CD4+ T cells
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiv219
  contributor:
    fullname: Siliciano, RF
– volume: 82
  start-page: 12335
  year: 2008
  end-page: 12345
  ident: B58
  article-title: Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells
  publication-title: J Virol
  doi: 10.1128/JVI.01181-08
  contributor:
    fullname: Cimarelli, A
– volume: 166
  start-page: 1433
  year: 2021
  end-page: 1438
  ident: B95
  article-title: Evaluation of kinase inhibitors as potential therapeutics for flavivirus infections
  publication-title: Arch Virol
  doi: 10.1007/s00705-021-05021-1
  contributor:
    fullname: Bonjardim, CA
– volume: 20
  start-page: 1726
  year: 2001
  end-page: 1738
  ident: B65
  article-title: The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation
  publication-title: EMBO J
  doi: 10.1093/emboj/20.7.1726
  contributor:
    fullname: Verdin, E
– volume: 46
  start-page: 2206
  year: 2008
  end-page: 2211
  ident: B105
  article-title: Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.00055-08
  contributor:
    fullname: Lukashov, VV
– volume: 21
  year: 2020
  ident: B24
  article-title: PEBP1 suppresses HIV-1 transcription and induces latency by inactivating MAPK/NF-κB signaling
  publication-title: EMBO Rep
  doi: 10.15252/embr.201949305
  contributor:
    fullname: Zhu, H
– volume: 28
  start-page: 663
  year: 2000
  end-page: 668
  ident: B6
  article-title: A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/28.3.663
  contributor:
    fullname: Deacon, NJ
– volume: 7
  start-page: 2229
  year: 2014
  end-page: 2237
  ident: B20
  article-title: A high throughput RNAi screen reveals determinants of HIV-1 activity in host kinases
  publication-title: Int J Clin Exp Pathol
  contributor:
    fullname: Lu, H-Z
– volume: 81
  start-page: 10914
  year: 2007
  end-page: 10923
  ident: B13
  article-title: c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter
  publication-title: J Virol
  doi: 10.1128/JVI.01208-07
  contributor:
    fullname: Margolis, DM
– ident: B104
  article-title: Ne E , Crespo R , Izquierdo-Lara R , Kocer S , Gorszka A , van Staveren T , Kan TW , Dekkers D , Rokx C , Moulos P , Hatzis P , Palstra R-J , Demmers J , Mahmoudi T . 2021 . dCas9 targeted chromatin and histone enrichment for mass spectrometry (Catchet-MS) identifies IKZF1 as a novel drug-able target for HIV-1 latency reversal . bioRxiv doi: 10.1101/2021.03.19.436149 .
– volume: 9
  start-page: 752
  year: 2014
  end-page: 766
  ident: B22
  article-title: Comprehensive identification of host modulators of HIV-1 replication using multiple orthologous RNAi reagents
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.09.031
  contributor:
    fullname: Brass, AL
– volume: 14
  start-page: 94
  year: 2016
  ident: B66
  article-title: The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells
  publication-title: J Transl Med
  doi: 10.1186/s12967-016-0853-5
  contributor:
    fullname: Tosi, G
– start-page: 23
  year: 2013
  end-page: 54
  ident: B69
  article-title: Adenosine metabolism, adenosine kinase, and evolution
  publication-title: Adenosine: a key link between metabolism and brain activity ;Springer ;New York, NY
  contributor:
    fullname: Boison, D
– volume: 41
  start-page: 3
  year: 2000
  end-page: 9
  ident: B73
  article-title: An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1157.2000.tb02163.x
  contributor:
    fullname: Maryanoff, BE
– volume: 252
  start-page: 273
  year: 1999
  end-page: 280
  ident: B34
  article-title: Isolation and characterization of a near-haploid human cell line
  publication-title: Exp Cell Res
  doi: 10.1006/excr.1999.4656
  contributor:
    fullname: Cochran, BH
– volume: 2017
  start-page: bax028
  year: 2017
  ident: B81
  article-title: GeneHancer: genome-wide integration of enhancers and target genes in GeneCards
  publication-title: Database
  doi: 10.1093/database/bax028
  contributor:
    fullname: Cohen, D
– volume: 25
  start-page: 207
  year: 2009
  end-page: 212
  ident: B7
  article-title: Expression of latent HIV-1 induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2008.0191
  contributor:
    fullname: Margolis, DM
– volume: 18
  start-page: 1101
  year: 2004
  end-page: 1108
  ident: B8
  article-title: Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression
  publication-title: AIDS
  doi: 10.1097/00002030-200405210-00003
  contributor:
    fullname: Margolis, DM
– volume: 135
  start-page: 417
  year: 2008
  end-page: 420
  ident: B25
  article-title: Knockdown screens to knockout HIV-1
  publication-title: Cell
  doi: 10.1016/j.cell.2008.10.007
  contributor:
    fullname: Goff, SP
– volume: 25
  start-page: 2607
  year: 2009
  end-page: 2608
  ident: B102
  article-title: ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp450
  contributor:
    fullname: Gentleman, R
– volume: 10
  start-page: 100
  year: 2019
  ident: B40
  article-title: BRCA2 deficiency instigates cGAS-mediated inflammatory signaling and confers sensitivity to tumor necrosis factor-alpha-mediated cytotoxicity
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-07927-y
  contributor:
    fullname: van Vugt, MATM
– volume: 549
  start-page: 106
  year: 2017
  end-page: 110
  ident: B41
  article-title: Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
  publication-title: Nature
  doi: 10.1038/nature23669
  contributor:
    fullname: Schumacher, TNM
– volume: 6
  start-page: 68
  year: 2009
  end-page: 80
  ident: B59
  article-title: A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2009.05.022
  contributor:
    fullname: Stevenson, M
– volume: 474
  start-page: 654
  year: 2011
  end-page: 657
  ident: B60
  article-title: SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
  publication-title: Nature
  doi: 10.1038/nature10117
  contributor:
    fullname: Benkirane, M
– volume: 8
  year: 2013
  ident: B45
  article-title: A reporter screen in a human haploid cell line identifies CYLD as a constitutive inhibitor of NF-κB
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0070339
  contributor:
    fullname: Ploegh, HL
– volume: 45
  start-page: 104
  year: 2013
  end-page: 108
  ident: B37
  article-title: MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
  publication-title: Nat Genet
  doi: 10.1038/ng.2471
  contributor:
    fullname: Sabatini, DM
– volume: 28
  start-page: 2685
  year: 2018
  end-page: 2696.e4
  ident: B42
  article-title: Loss of Kif18A results in spindle assembly checkpoint activation at microtubule-attached kinetochores
  publication-title: Curr Biol
  doi: 10.1016/j.cub.2018.06.026
  contributor:
    fullname: Raaijmakers, JA
– volume: 133
  start-page: jcs238865
  year: 2020
  ident: B75
  article-title: Pumping the brakes on RAS - negative regulators and death effectors of RAS
  publication-title: J Cell Sci
  doi: 10.1242/jcs.238865
  contributor:
    fullname: Clark, GJ
– volume: 115
  start-page: E7795
  year: 2018
  end-page: E7804
  ident: B19
  article-title: Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1803468115
  contributor:
    fullname: Karn, J
– volume: 76
  start-page: 3583
  year: 2019
  end-page: 3600
  ident: B18
  article-title: Strategies to eradicate HIV-1 from infected patients: elimination of latent provirus reservoirs
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-019-03156-8
  contributor:
    fullname: Hashemi, FB
– volume: 22
  start-page: 460
  year: 2017
  end-page: 470.e5
  ident: B49
  article-title: Diverse viruses require the calcium transporter SPCA1 for maturation and spread
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2017.09.002
  contributor:
    fullname: Rice, CM
– volume: 289
  start-page: 24005
  year: 2014
  end-page: 24018
  ident: B55
  article-title: GPR107, a G-protein-coupled receptor essential for intoxication by Pseudomonas aeruginosa exotoxin a, localizes to the Golgi and is cleaved by furin
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M114.589275
  contributor:
    fullname: Ploegh, HL
– volume: 3
  start-page: 1101
  year: 2008
  end-page: 1108
  ident: B103
  article-title: Analyzing real-time PCR data by the comparative C(T) method
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2008.73
  contributor:
    fullname: Livak, KJ
– volume: 563
  start-page: 559
  year: 2018
  end-page: 563
  ident: B52
  article-title: Protocadherin-1 is essential for cell entry by New World hantaviruses
  publication-title: Nature
  doi: 10.1038/s41586-018-0702-1
  contributor:
    fullname: Chandran, K
– volume: 279
  start-page: 42008
  year: 2004
  end-page: 42017
  ident: B14
  article-title: Prostratin antagonizes HIV-1 latency by activating NF-kappaB
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M402124200
  contributor:
    fullname: Greene, WC
– volume: 22
  start-page: 419
  year: 2018
  end-page: 437
  ident: B74
  article-title: Emerging therapeutic targets for neurofibromatosis type 1
  publication-title: Expert Opin Ther Targets
  doi: 10.1080/14728222.2018.1465931
  contributor:
    fullname: Upadhyaya, M
– volume: 195
  start-page: 751
  year: 2011
  end-page: 764
  ident: B54
  article-title: Identification of host cell factors required for intoxication through use of modified cholera toxin
  publication-title: J Cell Biol
  doi: 10.1083/jcb.201108103
  contributor:
    fullname: Ploegh, HL
– volume: 23
  start-page: 636
  year: 2018
  end-page: 643.e5
  ident: B51
  article-title: KREMEN1 is a host entry receptor for a major group of enteroviruses
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2018.03.019
  contributor:
    fullname: Brummelkamp, TR
– volume: 4
  year: 2018
  ident: B64
  article-title: Allele-specific long-distance regulation dictates IL-32 isoform switching and mediates susceptibility to HIV-1
  publication-title: Sci Adv
  doi: 10.1126/sciadv.1701729
  contributor:
    fullname: Mahmoudi, T
– volume: 326
  start-page: 1231
  year: 2009
  end-page: 1235
  ident: B35
  article-title: Haploid genetic screens in human cells identify host factors used by pathogens
  publication-title: Science
  doi: 10.1126/science.1178955
  contributor:
    fullname: Brummelkamp, TR
– volume: 10
  year: 2014
  ident: B91
  article-title: Activation of HIV-1 from latent infection via synergy of RUNX1 inhibitor Ro5-3335 and SAHA
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003997
  contributor:
    fullname: Jeang, K-T
– volume: 10
  start-page: 5350
  year: 2020
  ident: B26
  article-title: CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-62375-3
  contributor:
    fullname: Ho, DD
– volume: 20
  start-page: 785
  year: 2016
  end-page: 797
  ident: B21
  article-title: The mTOR complex controls HIV-1 latency
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2016.11.001
  contributor:
    fullname: Verdin, E
– volume: 83
  start-page: 746
  year: 2013
  end-page: 752
  ident: B72
  article-title: Ionotropic glutamate receptors: regulation by G-protein-coupled receptors
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.112.083352
  contributor:
    fullname: Dingledine, R
– volume: 340
  start-page: 479
  year: 2013
  end-page: 483
  ident: B47
  article-title: Deciphering the glycosylome of dystroglycanopathies using haploid screens for Lassa virus entry
  publication-title: Science
  doi: 10.1126/science.1233675
  contributor:
    fullname: Brummelkamp, TR
– volume: 487
  start-page: 439
  year: 2012
  end-page: 440
  ident: B3
  article-title: HIV-1: shock and kill
  publication-title: Nature
  doi: 10.1038/487439a
  contributor:
    fullname: Deeks, SG
– volume: 7
  year: 2012
  ident: B10
  article-title: Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0048832
  contributor:
    fullname: Zhu, H
– volume: 74
  start-page: 6790
  year: 2000
  end-page: 6799
  ident: B12
  article-title: The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1
  publication-title: J Virol
  doi: 10.1128/jvi.74.15.6790-6799.2000
  contributor:
    fullname: Margolis, DM
– volume: 335
  start-page: 191
  year: 2018
  end-page: 243
  ident: B4
  article-title: Transcription: insights from the HIV-1 promoter
  publication-title: Int Rev Cell Mol Biol
  doi: 10.1016/bs.ircmb.2017.07.011
  contributor:
    fullname: Mahmoudi, T
– volume: 25
  start-page: 139
  year: 2006
  end-page: 149
  ident: B11
  article-title: NF-κB p50 promotes HIV-1 latency through HDAC recruitment and repression of transcriptional initiation
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7600900
  contributor:
    fullname: Greene, WC
– volume: 10
  start-page: 733
  year: 2014
  ident: B31
  article-title: Measuring error rates in genomic perturbation screens: gold standards for human functional genomics
  publication-title: Mol Syst Biol
  doi: 10.15252/msb.20145216
  contributor:
    fullname: Moffat, J
– volume: 5
  start-page: 1144
  year: 2020
  end-page: 1157
  ident: B88
  article-title: FOXO1 promotes HIV-1 latency by suppressing ER stress in T cells
  publication-title: Nat Microbiol
  doi: 10.1038/s41564-020-0742-9
  contributor:
    fullname: Ott, M
– volume: 8
  year: 2013
  ident: B71
  article-title: Identification of 5-iodotubercidin as a genotoxic drug with anti-cancer potential
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0062527
  contributor:
    fullname: Li, B
– volume: 12
  start-page: 4503
  year: 2021
  ident: B86
  article-title: Stochastic pausing at latent HIV-1 promoters generates transcriptional bursting
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-24462-5
  contributor:
    fullname: Bertrand, E
– volume: 128
  start-page: 317
  year: 2015
  end-page: 330
  ident: B53
  article-title: BRG1 promotes the repair of DNA double-strand breaks by facilitating the replacement of RPA with RAD51
  publication-title: J Cell Sci
  doi: 10.1242/jcs.159103
  contributor:
    fullname: Zeng, X
– volume: 10
  year: 2014
  ident: B17
  article-title: Activation of HIV-1 transcription with short-course vorinostat in HIV-1-infected patients on suppressive antiretroviral therapy
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1004473
  contributor:
    fullname: Lewin, SR
– volume: 38
  start-page: 37
  year: 2019
  end-page: 53
  ident: B92
  article-title: A broad drug arsenal to attack a strenuous latent HIV-1 reservoir
  publication-title: Curr Opin Virol
  doi: 10.1016/j.coviro.2019.06.001
  contributor:
    fullname: Mahmoudi, T
– volume: 350
  start-page: 1092
  year: 2015
  end-page: 1096
  ident: B44
  article-title: Gene essentiality and synthetic lethality in haploid human cells
  publication-title: Science
  doi: 10.1126/science.aac7557
  contributor:
    fullname: Brummelkamp, TR
– volume: 32
  start-page: 2783
  year: 2002
  end-page: 2791
  ident: B67
  article-title: The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication
  publication-title: Eur J Immunol
  doi: 10.1002/1521-4141(2002010)32:10<2783::AID-IMMU2783>3.0.CO;2-E
  contributor:
    fullname: Tosi, G
– volume: 117
  start-page: 15763
  year: 2020
  end-page: 15771
  ident: B89
  article-title: HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs in vitro and ex vivo
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1916290117
  contributor:
    fullname: Siliciano, RF
– volume: 9
  year: 2011
  ident: B57
  article-title: Repressive LTR nucleosome positioning by the BAF complex is required for HIV-1 latency
  publication-title: PLoS Biol
  doi: 10.1371/journal.pbio.1001206
  contributor:
    fullname: Mahmoudi, T
– volume: 25
  start-page: 612
  year: 2019
  end-page: 619
  ident: B38
  article-title: Glutaminyl cyclase is an enzymatic modifier of the CD47-SIRPα axis and a target for cancer immunotherapy
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0356-z
  contributor:
    fullname: Schumacher, TN
– volume: 65
  start-page: 906
  year: 2013
  end-page: 943
  ident: B70
  article-title: Adenosine kinase: exploitation for therapeutic gain
  publication-title: Pharmacol Rev
  doi: 10.1124/pr.112.006361
  contributor:
    fullname: Boison, D
– volume: 14
  start-page: 1315
  year: 1998
  end-page: 1322
  ident: B94
  article-title: Phosphorylation of triciribine is necessary for activity against HIV type 1
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.1998.14.1315
  contributor:
    fullname: Drach, JC
– volume: 96
  start-page: 296
  year: 2012
  end-page: 304
  ident: B93
  article-title: Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus
  publication-title: Antiviral Res
  doi: 10.1016/j.antiviral.2012.09.021
  contributor:
    fullname: Gershburg, E
– volume: 541
  start-page: 412
  year: 2017
  end-page: 416
  ident: B48
  article-title: PLA2G16 represents a switch between entry and clearance of Picornaviridae
  publication-title: Nature
  doi: 10.1038/nature21032
  contributor:
    fullname: Brummelkamp, TR
– volume: 26
  start-page: 703
  year: 2019
  end-page: 705
  ident: B85
  article-title: HIV-1 latency: stochastic across multiple scales
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2019.11.010
  contributor:
    fullname: Weinberger, LS
– volume: 14
  year: 2019
  ident: B39
  article-title: SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0212053
  contributor:
    fullname: Schumacher, TN
– volume: 7
  start-page: a026450
  year: 2017
  ident: B68
  article-title: The chromodomain helicase DNA-binding chromatin remodelers: family traits that protect from and promote cancer
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a026450
  contributor:
    fullname: Mills, AA
– volume: 108
  start-page: 11756
  year: 2011
  end-page: 11765
  ident: B36
  article-title: A haploid genetic screen identifies the major facilitator domain containing 2A (MFSD2A) transporter as a key mediator in the response to tunicamycin
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1018098108
  contributor:
    fullname: Sabatini, DM
– volume: 41
  start-page: 17
  year: 2000
  end-page: 20
  ident: B100
  article-title: Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1157.2000.tb02165.x
  contributor:
    fullname: Wolf, HH
– volume: 36
  start-page: 884
  year: 1996
  end-page: 891
  ident: B97
  article-title: Single-dose pharmacokinetics and effect of food on the bioavailability of topiramate, a novel antiepileptic drug
  publication-title: J Clin Pharmacol
  doi: 10.1002/j.1552-4604.1996.tb04754.x
  contributor:
    fullname: Nayak, RK
– volume: 487
  start-page: 482
  year: 2012
  end-page: 485
  ident: B16
  article-title: Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
  publication-title: Nature
  doi: 10.1038/nature11286
  contributor:
    fullname: Margolis, DM
– volume: 22
  start-page: 688
  year: 2017
  end-page: 696.e5
  ident: B50
  article-title: NRP2 and CD63 are host factors for Lujo virus cell entry
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2017.10.002
  contributor:
    fullname: Whelan, SP
– volume: 160
  start-page: 990
  year: 2015
  end-page: 1001
  ident: B84
  article-title: A hardwired HIV-1 latency program
  publication-title: Cell
  doi: 10.1016/j.cell.2015.02.009
  contributor:
    fullname: Weinberger, LS
– volume: 233
  start-page: 80
  year: 2011
  end-page: 89
  ident: B98
  article-title: Glutamate signaling through the kainate receptor enhances human immunoglobulin production
  publication-title: J Neuroimmunol
  doi: 10.1016/j.jneuroim.2010.11.014
  contributor:
    fullname: Conrad, DH
– volume: 91
  start-page: 79
  year: 1994
  end-page: 89
  ident: B87
  article-title: HIV-1 reactivation after an oxidative stress mediated by different reactive oxygen species
  publication-title: Chem Biol Interact
  doi: 10.1016/0009-2797(94)90028-0
  contributor:
    fullname: Legrand-Poels, S
– volume: 48
  start-page: 872
  year: 2018
  end-page: 895
  ident: B2
  article-title: Targeting the latent reservoir for HIV-1
  publication-title: Immunity
  doi: 10.1016/j.immuni.2018.04.030
  contributor:
    fullname: Siliciano, RF
– volume: 16
  start-page: 1199
  year: 2020
  end-page: 1207
  ident: B63
  article-title: Rational discovery of molecular glue degraders via scalable chemical profiling
  publication-title: Nat Chem Biol
  doi: 10.1038/s41589-020-0594-x
  contributor:
    fullname: Winter, GE
– volume: 44
  start-page: 1521
  year: 2003
  end-page: 1528
  ident: B101
  article-title: Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate
  publication-title: Epilepsia
  doi: 10.1111/j.0013-9580.2003.06203.x
  contributor:
    fullname: Desai, PB
– volume: 47
  start-page: 7333
  year: 2019
  end-page: 7347
  ident: B28
  article-title: A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG)
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkz493
  contributor:
    fullname: Zhu, J
– volume: 8
  start-page: 418
  year: 2010
  end-page: 429
  ident: B15
  article-title: Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency
  publication-title: Curr HIV Res
  doi: 10.2174/157016210793499312
  contributor:
    fullname: Muñoz, E
– volume: 22
  start-page: 1868
  year: 2003
  end-page: 1877
  ident: B56
  article-title: HIV-1 reproducibly establishes a latent infection after acute infection of T cells in vitro
  publication-title: EMBO J
  doi: 10.1093/emboj/cdg188
  contributor:
    fullname: Verdin, E
– volume: 15
  start-page: 741
  year: 2018
  end-page: 747
  ident: B82
  article-title: Trac-looping measures genome structure and chromatin accessibility
  publication-title: Nat Methods
  doi: 10.1038/s41592-018-0107-y
  contributor:
    fullname: Zhao, K
– volume: 164-165
  start-page: 29
  year: 2019
  end-page: 35
  ident: B33
  article-title: Genome-wide CRISPR-Cas9 screening in mammalian cells
  publication-title: Methods
  doi: 10.1016/j.ymeth.2019.04.015
  contributor:
    fullname: Yusa, K
– volume: 6
  year: 2020
  ident: B78
  article-title: Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency
  publication-title: Sci Adv
  doi: 10.1126/sciadv.aba6617
  contributor:
    fullname: Mahmoudi, T
– volume: 21
  start-page: 569
  year: 2017
  end-page: 579.e6
  ident: B32
  article-title: SMYD2-mediated histone methylation contributes to HIV-1 latency
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2017.04.011
  contributor:
    fullname: Ott, M
– volume: 6
  start-page: 1837
  year: 2014
  end-page: 1860
  ident: B79
  article-title: HIV-1 latency in monocytes/macrophages
  publication-title: Viruses
  doi: 10.3390/v6041837
  contributor:
    fullname: Herbein, G
– volume: 7
  year: 2012
  ident: B77
  article-title: A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0030176
  contributor:
    fullname: Greene, WC
– volume: 4
  start-page: 646
  year: 2013
  end-page: 665
  ident: B30
  article-title: In vivo RNAi-based screens: studies in model organisms
  publication-title: Genes (Basel)
  doi: 10.3390/genes4040646
  contributor:
    fullname: Goto, S
– volume: 495
  start-page: 1846
  year: 2018
  end-page: 1850
  ident: B96
  article-title: Trametinib suppresses HIV-1 replication by interfering with the disassembly of human immunodeficiency virus type 1 capsid core
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2017.11.177
  contributor:
    fullname: Misumi, S
– volume: 231
  start-page: 123
  year: 1997
  end-page: 126
  ident: B99
  article-title: Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells
  publication-title: Neurosci Lett
  doi: 10.1016/s0304-3940(97)00543-0
  contributor:
    fullname: Avoli, M
– volume: 10
  start-page: 1435
  year: 2019
  ident: B80
  article-title: The HIV-1 reservoir in monocytes and macrophages
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01435
  contributor:
    fullname: Hearps, AC
– volume: 100
  start-page: 9918
  year: 2003
  end-page: 9922
  ident: B61
  article-title: A large-scale, gene-driven mutagenesis approach for the functional analysis of the mouse genome
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1633296100
  contributor:
    fullname: Ruiz, P
– volume: 73
  start-page: 1245
  year: 2013
  end-page: 1254
  ident: B76
  article-title: Trametinib: first global approval
  publication-title: Drugs
  doi: 10.1007/s40265-013-0096-1
  contributor:
    fullname: McCormack, PL
– volume: 31
  start-page: 2889
  year: 2011
  end-page: 2901
  ident: B83
  article-title: Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.00974-10
  contributor:
    fullname: Viola, JPB
– ident: e_1_3_2_18_2
  doi: 10.1371/journal.ppat.1004473
– ident: e_1_3_2_30_2
  doi: 10.1146/annurev.genom.8.080706.092424
– ident: e_1_3_2_2_2
  doi: 10.1093/infdis/jiv219
– ident: e_1_3_2_38_2
  doi: 10.1038/ng.2471
– ident: e_1_3_2_32_2
  doi: 10.15252/msb.20145216
– ident: e_1_3_2_54_2
  doi: 10.1242/jcs.159103
– ident: e_1_3_2_20_2
  doi: 10.1073/pnas.1803468115
– ident: e_1_3_2_37_2
  doi: 10.1073/pnas.1018098108
– ident: e_1_3_2_39_2
  doi: 10.1038/s41591-019-0356-z
– ident: e_1_3_2_58_2
  doi: 10.1371/journal.pbio.1001206
– ident: e_1_3_2_64_2
  doi: 10.1038/s41589-020-0594-x
– ident: e_1_3_2_5_2
  doi: 10.1016/bs.ircmb.2017.07.011
– ident: e_1_3_2_105_2
  doi: 10.2139/ssrn.3553972
– ident: e_1_3_2_93_2
  doi: 10.1016/j.coviro.2019.06.001
– ident: e_1_3_2_83_2
  doi: 10.1038/s41592-018-0107-y
– ident: e_1_3_2_81_2
  doi: 10.3389/fimmu.2019.01435
– ident: e_1_3_2_92_2
  doi: 10.1371/journal.ppat.1003997
– ident: e_1_3_2_24_2
  doi: 10.1371/journal.ppat.1009055
– ident: e_1_3_2_61_2
  doi: 10.1038/nature10117
– ident: e_1_3_2_36_2
  doi: 10.1126/science.1178955
– ident: e_1_3_2_85_2
  doi: 10.1016/j.cell.2015.02.009
– ident: e_1_3_2_60_2
  doi: 10.1016/j.chom.2009.05.022
– ident: e_1_3_2_3_2
  doi: 10.1016/j.immuni.2018.04.030
– ident: e_1_3_2_52_2
  doi: 10.1016/j.chom.2018.03.019
– ident: e_1_3_2_35_2
  doi: 10.1006/excr.1999.4656
– ident: e_1_3_2_73_2
  doi: 10.1124/mol.112.083352
– ident: e_1_3_2_19_2
  doi: 10.1007/s00018-019-03156-8
– ident: e_1_3_2_88_2
  doi: 10.1016/0009-2797(94)90028-0
– ident: e_1_3_2_49_2
  doi: 10.1038/nature21032
– ident: e_1_3_2_14_2
  doi: 10.1128/JVI.01208-07
– ident: e_1_3_2_33_2
  doi: 10.1016/j.chom.2017.04.011
– ident: e_1_3_2_27_2
  doi: 10.1038/s41598-020-62375-3
– ident: e_1_3_2_68_2
  doi: 10.1002/1521-4141(2002010)32:10<2783::AID-IMMU2783>3.0.CO;2-E
– ident: e_1_3_2_102_2
  doi: 10.1111/j.0013-9580.2003.06203.x
– ident: e_1_3_2_6_2
  doi: 10.1186/1742-4690-10-67
– ident: e_1_3_2_99_2
  doi: 10.1016/j.jneuroim.2010.11.014
– ident: e_1_3_2_11_2
  doi: 10.1371/journal.pone.0048832
– ident: e_1_3_2_106_2
  doi: 10.1128/JCM.00055-08
– ident: e_1_3_2_29_2
  doi: 10.1093/nar/gkz493
– ident: e_1_3_2_42_2
  doi: 10.1038/nature23669
– ident: e_1_3_2_44_2
  doi: 10.1016/j.celrep.2018.01.034
– ident: e_1_3_2_78_2
  doi: 10.1371/journal.pone.0030176
– ident: e_1_3_2_26_2
  doi: 10.1016/j.cell.2008.10.007
– ident: e_1_3_2_76_2
  doi: 10.1242/jcs.238865
– ident: e_1_3_2_56_2
  doi: 10.1074/jbc.M114.589275
– ident: e_1_3_2_96_2
  doi: 10.1007/s00705-021-05021-1
– ident: e_1_3_2_17_2
  doi: 10.1038/nature11286
– ident: e_1_3_2_40_2
  doi: 10.1371/journal.pone.0212053
– ident: e_1_3_2_67_2
  doi: 10.1186/s12967-016-0853-5
– ident: e_1_3_2_86_2
  doi: 10.1016/j.chom.2019.11.010
– ident: e_1_3_2_50_2
  doi: 10.1016/j.chom.2017.09.002
– ident: e_1_3_2_80_2
  doi: 10.3390/v6041837
– ident: e_1_3_2_51_2
  doi: 10.1016/j.chom.2017.10.002
– ident: e_1_3_2_47_2
  doi: 10.1038/nature10348
– ident: e_1_3_2_70_2
  doi: 10.1007/978-1-4614-3903-5_2
– ident: e_1_3_2_97_2
  doi: 10.1016/j.bbrc.2017.11.177
– ident: e_1_3_2_59_2
  doi: 10.1128/JVI.01181-08
– ident: e_1_3_2_43_2
  doi: 10.1016/j.cub.2018.06.026
– ident: e_1_3_2_101_2
  doi: 10.1111/j.1528-1157.2000.tb02165.x
– ident: e_1_3_2_62_2
  doi: 10.1073/pnas.1633296100
– ident: e_1_3_2_66_2
  doi: 10.1093/emboj/20.7.1726
– ident: e_1_3_2_10_2
  doi: 10.1371/journal.ppat.1004071
– ident: e_1_3_2_98_2
  doi: 10.1002/j.1552-4604.1996.tb04754.x
– ident: e_1_3_2_41_2
  doi: 10.1038/s41467-018-07927-y
– ident: e_1_3_2_94_2
  doi: 10.1016/j.antiviral.2012.09.021
– ident: e_1_3_2_77_2
  doi: 10.1007/s40265-013-0096-1
– ident: e_1_3_2_23_2
  doi: 10.1016/j.celrep.2014.09.031
– ident: e_1_3_2_9_2
  doi: 10.1097/00002030-200405210-00003
– ident: e_1_3_2_46_2
  doi: 10.1371/journal.pone.0070339
– ident: e_1_3_2_87_2
  doi: 10.1038/s41467-021-24462-5
– ident: e_1_3_2_104_2
  doi: 10.1038/nprot.2008.73
– ident: e_1_3_2_28_2
  doi: 10.1371/journal.ppat.1008834
– ident: e_1_3_2_63_2
  doi: 10.1371/journal.pcbi.1005950
– ident: e_1_3_2_48_2
  doi: 10.1126/science.1233675
– ident: e_1_3_2_82_2
  doi: 10.1093/database/bax028
– ident: e_1_3_2_100_2
  doi: 10.1016/s0304-3940(97)00543-0
– ident: e_1_3_2_45_2
  doi: 10.1126/science.aac7557
– ident: e_1_3_2_22_2
  doi: 10.1016/j.chom.2016.11.001
– ident: e_1_3_2_71_2
  doi: 10.1124/pr.112.006361
– ident: e_1_3_2_90_2
  doi: 10.1073/pnas.1916290117
– ident: e_1_3_2_89_2
  doi: 10.1038/s41564-020-0742-9
– ident: e_1_3_2_69_2
  doi: 10.1101/cshperspect.a026450
– ident: e_1_3_2_74_2
  doi: 10.1111/j.1528-1157.2000.tb02163.x
– ident: e_1_3_2_84_2
  doi: 10.1128/MCB.00974-10
– ident: e_1_3_2_75_2
  doi: 10.1080/14728222.2018.1465931
– ident: e_1_3_2_8_2
  doi: 10.1089/aid.2008.0191
– ident: e_1_3_2_57_2
  doi: 10.1093/emboj/cdg188
– ident: e_1_3_2_95_2
  doi: 10.1089/aid.1998.14.1315
– ident: e_1_3_2_31_2
  doi: 10.3390/genes4040646
– ident: e_1_3_2_15_2
  doi: 10.1074/jbc.M402124200
– ident: e_1_3_2_13_2
  doi: 10.1128/jvi.74.15.6790-6799.2000
– volume: 7
  start-page: 2229
  year: 2014
  ident: e_1_3_2_21_2
  article-title: A high throughput RNAi screen reveals determinants of HIV-1 activity in host kinases
  publication-title: Int J Clin Exp Pathol
  contributor:
    fullname: Jiang W-M
– ident: e_1_3_2_34_2
  doi: 10.1016/j.ymeth.2019.04.015
– ident: e_1_3_2_103_2
  doi: 10.1093/bioinformatics/btp450
– ident: e_1_3_2_55_2
  doi: 10.1083/jcb.201108103
– ident: e_1_3_2_91_2
  doi: 10.1145/1645953.1646195
– ident: e_1_3_2_7_2
  doi: 10.1093/nar/28.3.663
– ident: e_1_3_2_72_2
  doi: 10.1371/journal.pone.0062527
– ident: e_1_3_2_79_2
  doi: 10.1126/sciadv.aba6617
– ident: e_1_3_2_65_2
  doi: 10.1126/sciadv.1701729
– ident: e_1_3_2_53_2
  doi: 10.1038/s41586-018-0702-1
– ident: e_1_3_2_12_2
  doi: 10.1038/sj.emboj.7600900
– ident: e_1_3_2_4_2
  doi: 10.1038/487439a
– ident: e_1_3_2_16_2
  doi: 10.2174/157016210793499312
– ident: e_1_3_2_25_2
  doi: 10.15252/embr.201949305
SSID ssj0000331830
Score 2.3794568
Snippet To identify novel host factors as putative targets to reverse HIV-1 latency, we performed an insertional mutagenesis genetic screen in a latent HIV-1 infected...
A reservoir of latently HIV-1-infected cells persists in the presence of combination antiretroviral therapy (cART), representing a major obstacle for viral...
ABSTRACT To identify novel host factors as putative targets to reverse HIV-1 latency, we performed an insertional mutagenesis genetic screen in a latent HIV-1...
SourceID doaj
pubmedcentral
proquest
crossref
asm2
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0298021
SubjectTerms CD4-Positive T-Lymphocytes - metabolism
CD4-Positive T-Lymphocytes - virology
DNA Helicases - genetics
DNA Helicases - metabolism
DNA-Binding Proteins - genetics
DNA-Binding Proteins - metabolism
Gene Expression Regulation, Viral
Genetics and Molecular Biology
haploid forward genetic screen
Haploidy
HIV Infections - genetics
HIV Infections - metabolism
HIV Infections - virology
HIV-1 - genetics
HIV-1 - physiology
host factor
Host-Pathogen Interactions
human immunodeficiency virus
Humans
latency
Receptors, Kainic Acid - genetics
Receptors, Kainic Acid - metabolism
Research Article
Trans-Activators - genetics
Trans-Activators - metabolism
Transcription Factors - genetics
Transcription Factors - metabolism
Ubiquitin-Specific Proteases - genetics
Ubiquitin-Specific Proteases - metabolism
Virus Activation
Virus Latency
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEF_0QPBF_Datyori29pkk_16bGuPFKQvrSK-LJvbHTxok9LcVfrfdya5O3qi-OJjkoUsM7Mzv2FnfsPYh0KnIiYZBTVNiqpMVgRrQWjtUtNUJthI3cj1qTn5bj8fEU3OZtQX1YSN9MCj4PYkIPyLliKroUtC50I5c6CKlPIUHAzeNzd3kqnBB5dkq_maVFPavYuDefeJ-MZzQbygk9BfyK1YNFD2_wln_l4ueSf-TB-zRyvgyPfHDT9h91L7lD0YR0nePGM_9vnZr04c4uMVr8PleTePnDilcTk_nVF1DR-bcgFzY37SXadzXnf9gk_HiTv8uEVPdZ0in7e8Pv4mCv4lEKC-ec6-To_ODmuxmpsggirlQsxAm6oBBRjfgwrGBExDIJhmFqBxCJmiqbREIVbJORVkhTkHTcl0MaSKCNtesEnbtekVdXTn4IBwCYZxAIxlkAdtQKlSgZIxY-9JkH5l-L0fcgppPYnbD-L2ssjYx7Wc_eVIovG3hQekhc0i4r4eXqBF-JVF-H9ZRMberXXo8azQBUhoU7fsPeZuRjn0OTJjL0edbn5VYuYmS6UzZra0vbWX7S_t_OfAx211hSha7_yPze-yh5KqZgqJZvqaTRZXy_SG3e_j8u1g4bdskP0J
  priority: 102
  providerName: Directory of Open Access Journals
Title A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency
URI https://www.ncbi.nlm.nih.gov/pubmed/34872356
https://journals.asm.org/doi/10.1128/mBio.02980-21
https://search.proquest.com/docview/2607591962
https://pubmed.ncbi.nlm.nih.gov/PMC8649776
https://doaj.org/article/2f729d806387452999a3c9f51ee0ea9f
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dj5QwEG_cTUx8MX6LH5cajW_sQqGUPt6tt-ESvZjcaYwvTaGtkuzCZtk9c_-9MwUut0ZffARKKDND5zd05jeEvIszGxvLTIhFk2Ga2DzUee7CLJO2LFOhc4PVyMWFOP-WfzhFmhw-1sL4pP2qrGfNaj1r6p8-t3KzruZjntj886dFnqUAW7L5hEwAG94K0f3ym6CZRiOfJsvn65O6nSHVeBQy7AyTAEhnCbasnupuzQ48kifu_xva_DNp8pYXWj4g9wf4SI_7aT4kd2zziNztG0pePybfj-nlrzZcwOGWFnqzamtDkVkahtOLCnNsaF-a6yBCpuftlV3Rou12dNn33aFnDaxXV9bQuqHF2dcwph81wurrJ-TL8vRyUYRD94RQ84TtwsplIi0dd-DlNddCaAhGnBZlpV0pATgZkWaski61UnLNUog8sFemNNqmSNv2lEybtrHPsa47ctIhOgFn7hx4NBfpTDjOE-44MwF5i4JUg_l3ykcWLFcoeeUlr1gckPejnNWmp9L418AT1MLNIGTA9ifa7Q812IFiDlRvckRcAjePpdQJvAyPrY2sli4gb0YdKvhicBtEN7bddwoiOMElrDwsIM96nd48ajSNgIgDbR_M5fAKGKln5R6M8sV_3_mS3GOYMBMzMNNXZLrb7u1rMunM_sj_KTjydv4b0Lz_Cw
link.rule.ids 230,315,729,782,786,866,887,2107,27934,27935,53802,53804
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdYEYIXvgcZX0Yg3twmThzHj1tZlYquQlpBiBfLiW2I1CZV027af48vH9OK4GWPiS9KnLuzfyff_Q6hj0FsAm2oJlA0SaLQJEQliSVxLEyWRVwlGqqR03M-_5F8PgWaHNbXwjRJ-3lWDMvlalgWv5vcyvUqH_V5YqOvZ-MkjhxsiUcH6K7zV5_eCNKbBTgEQ_V7Rk2ajFYnRTUEsnGfUOgNEzqYTkNoWj1Q9Yru7UkNdf-_8ObfaZM39qHJo1vO4DF62AFPfNwOP0F3TPkU3WtbUV49Qz-P8eKyImN3ucGpWi-rQmPgpHbi-DyH7BzcFvVaF1vjeXVhljit6i2etB178LR0K92F0bgocTr9TgI8UwDIr56jb5PTxTglXd8FolhItyS3MY8yy6zDB4opzpULY6ziWa5sJhzk0jyKaS5sZIRgikYuZoEum0IrEwHh2yEalFVpXkJFuG-FBVzjYIC1bi-0voq5ZSxkllHtoQ-gANk5Ti2bmIQmEjQmG41JGnjoU68fuW5JOP4neALauxYC7uzmRrX5Jbv_L6l1AYVOAKtxOHYWQoVuMiwwxjdKWA-973Uvna_BAYoqTbWrpYv9OBNuzaIeetHawvWrepPyEN-zkr1v2R9xxtHweXfGcHTrJ9-h--nibCZn0_mXV-gBhbSbgDpTf40G283OvEEHtd69bbzkD6wXE74
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELbYIhAX3o_wNAJxc5M4cRwfd7tbpWKpVtoFIS6WE9sQqU2qpl20_x5PHtUWwQWOSSZKrHn4G3nmG4Teh4kJtaGaQNMkiSOTEpWmliSJMHkec5Vq6EbOzvn8a3p8AjQ5u1FfbdF-kZfjarEcV-WPtrZytSz8oU7MP_s0SZPYwZbEX2nrH6CbzmeD-Fqi3gbhCIw1GFg1aeovj8p6DITjAaEwHyZyUJ1GMLh6pJol3duXWvr-P2HO30snr-1F03v_sYr76G4PQPFhJ_IA3TDVQ3SrG0l59Qh9O8QXP2sycZdrnKnVoi41Bm5qJ47PC6jSwV1zr3U5Np7Xl2aBs7rZ4Gk3uQfPKhfxLo3GZYWz2RcS4lMFwPzqMfo8PbmYZKSfv0AUi-iGFDbhcW6ZdThBMcW5cumMVTwvlM2Fg16axwkthI2NEEzR2OUuMG1TaGViIH57gkZVXZln0BkeWGEB3zg4YK3bE22gEm4Zi5hlVHvoHShB9g7UyDY3oakErclWa5KGHvow6EiuOjKOvwkegQZ3QsCh3d6o199lrwNJrUssdAqYjcPxsxAqcothoTGBUcJ66O2gf-l8Dg5SVGXqbSNdDsiZcLGLeuhpZw-7Tw1m5SG-Zyl7_7L_xBlIy-vdG8Tzf37zDbp9djyVp7P5xxfoDoXqm5A6a3-JRpv11rxCB43evm4d5RdwaRY-
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Two-Color+Haploid+Genetic+Screen+Identifies+Novel+Host+Factors+Involved+in+HIV-1+Latency&rft.jtitle=mBio&rft.au=R%C3%B6ling%2C+Michael&rft.au=Mollapour+Sisakht%2C+Mahsa&rft.au=Ne%2C+Enrico&rft.au=Moulos%2C+Panagiotis&rft.date=2021-12-21&rft.eissn=2150-7511&rft.volume=12&rft.issue=6&rft.spage=e0298021&rft.epage=e0298021&rft_id=info:doi/10.1128%2FmBio.02980-21&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2150-7511&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2150-7511&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2150-7511&client=summon